23andMe's new BRCA1/BRCA2 (Selected Variants) report looks at three variants in the BRCA1 and BRCA2 genes associated with an increased risk of breast, ovarian and prostate cancer. These three variants are most common in people of Ashkenazi Jewish descent, but having one of these variants carries serious risk no matter your ancestry.

Every day at 23andMe is a research day.Joyce Tung, 23andMe’s Vice President of Research, listening in on sequencing and imputation.But recently, we had our very first “23andMe Genome Research Day”,...

The U.S. Food and Drug Administration granted 23andMe authorization to offer ten genetic health risk reports including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease, and a condition associated with harmful...